Amendment of Restatement & Republishing Materiality Threshold for CME CF Cryptocurrency Pricing Products

The Administrator announces that the Restatement & Republishing materiality threshold for all Reference Rates within the CME CF Cryptocurrency Pricing Products will be amended on June 11th, 2024.

Amendment of Restatement & Republishing Materiality Threshold for CME CF Cryptocurrency Pricing Products

The Administrator announces that the Restatement & Republishing materiality threshold for all Reference Rates within the CME CF Cryptocurrency Pricing Products will be amended on June 11th, 2024.

The Restatement & Republishing materiality threshold will be amended from 0.20% to 0.10%. This change will be implemented at 11:00 London Time on June 11th, 2024.

Going forward, this means the Administrator will only Restate and Republish CME CF Cryptocurrency Reference Rates when the following conditions are met:

  1. Timeliness – where the Administrator can RESTATE and REPUBLISH a CME Cryptocurrency Reference Rate value before 23:59:59 of the given Calculation Day
  2. Materiality - where the RESTATED CME CF Cryptocurrency Reference Rate has an absolute variance greater than 0.10% for the respective CME CF Cryptocurrency Reference Rate of the given Calculation Day

In case of any questions or queries please do not hesitate to contact info@cfbenchmarks.com.

Any users wishing to file a complaint regarding this process can do so confidentially by writing to complaints@cfbenchmarks.com.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.